Comprehensive molecular characterization of myeloid malignancies with 9q deletion

Click to increase image sizeClick to decrease image size

Acknowledgements

The authors would like to thank all coworkers at the MLL Munich Leukemia Laboratory for approaching together many aspects in the field of leukemia diagnostics and research by their dedicated work. The authors would like to thank all physicians for providing samples and caring for patients as well as collecting data.

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at https://doi.org/10.1080/10428194.2019.1585840.

Additional information

Funding

CH, WK and TH declare part ownership of Munich Leukemia Laboratory (MLL). LH, AS and MM are employed by the MLL Munich Leukemia Laboratory